FORT WORTH, Texas, Jan. 12 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (WNDM), has named Deborah Jenkins Hutchison as its new president to help spearhead WNDM's leveraging of its existing technology and infrastructure to develop opportunities in the rapidly growing markets of biotech and genetic engineering, and to expand WNDM's technology footprint. WNDM noted that the appointment is extremely timely in light of their upcoming acquisition of Secure eHealth, a technology provider for Wound Care Innovations and for Private Access, an Irvine based innovator in privacy-enhanced search technology who is collaborating with Pfizer and the Genetic Alliance to develop an online community to accelerate clinical research.
"Earlier this week it was announced earlier this week that Wound Management is in final contract negotiations to acquire secure messaging and data provider, Secure eHealth to expand WNDM's technology footprint," said Scott Haire, Chairman of WNDM. "Hutchinson's experience leading several biomedical companies and her participation on the boards of several healthcare technology firms including the board of directors and advisory committees for Private Access, Inc. and VirtualHealth Technologies, Inc. strategically places her as the key instrument in the company's surge forward as we push to make the most of our assets and transition to profitability in 2010."
Hutchinson's career with over 30 years experience in the healthcare and technology sectors is highlighted with a track record in successfully taking early development healthcare and biotech companies from concept to product development and finally sales. She is an inventor and co-inventor of multiple US patents for pharmacy, telemedicine and other technical applications, and has led numerous initiatives in the healthcare technology arena. Hutchinson brings international business experience to WNDM, with past experience in Europe, China, the Americas, and Asia. She has served most recently as Executive Vice-President of Business Development with HEB LLC, a private investment company with operating divisions in healthcare, bio-medicine and technology.
When asked about the opportunity, Hutchinson was quoted as saying "I am very much looking forward to working with Wound Management and in using my experience in the industry to help them achieve the kind of success that both we in management and our shareholders know is capable with our business model." Hutchinson continued, "I am especially excited to be working directly with Secure eHealth. They are a perfect fit for us and with their existing relationships and our anticipated expansion we can build tremendous value for the company."
In a related announcement WNDM stated that in response to its Bio Pharma Management Technologies subsidiary's call for partners issued in November, they are currently evaluating acquisitions and opportunities in the genetic engineering and biotechnology markets as they relate to the company's core business model. Details will be released as they become available.
For Wound Management Technologies Shareholder Information please call 954-357-0614 or go to http://www.woundmanagementtechnologies.com
About Wound Management Technologies, Inc.
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, and regional offices in Ft. Lauderdale, Florida is a rapidly growing provider of specialty medical products and advanced biotechnology solutions. The Company is following the lead of NASDAQ Biotech Stock INDEX leaders such as Celgene (CELG) http://www.celgene.com, Geron (GERN) http://www.geron.com, and Human Genome Sciences (HGSI) http://www.hgsi.com by working to leverage its existing technology and infrastructure to develop opportunities within the International Biotechnology and Genetic Engineering fields. WNDM also has an interest in Cancer Treatment. For more information on the Company please visit http://www.woundmanagementtechnologies.com
"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995:
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.
For Further Information:
Shareholder Relations-Communications 954-357-0614
SOURCE Wound Management Technologies, Inc.